vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and WOLFSPEED, INC. (WOLF). Click either name above to swap in a different company.

WOLFSPEED, INC. is the larger business by last-quarter revenue ($168.5M vs $164.7M, roughly 1.0× PTC THERAPEUTICS, INC.). PTC THERAPEUTICS, INC. runs the higher net margin — -82.0% vs -89.4%, a 7.4% gap on every dollar of revenue. On growth, WOLFSPEED, INC. posted the faster year-over-year revenue change (-6.6% vs -22.7%). PTC THERAPEUTICS, INC. produced more free cash flow last quarter ($-36.6M vs $-72.6M). Over the past eight quarters, WOLFSPEED, INC.'s revenue compounded faster (-8.4% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Wolfspeed, Inc. is an American developer and manufacturer of wide-bandgap semiconductors, focused on silicon carbide materials and devices for power applications such as transportation, power supplies, power inverters, and wireless systems. The company was formerly named Cree, Inc.

PTCT vs WOLF — Head-to-Head

Bigger by revenue
WOLF
WOLF
1.0× larger
WOLF
$168.5M
$164.7M
PTCT
Growing faster (revenue YoY)
WOLF
WOLF
+16.1% gap
WOLF
-6.6%
-22.7%
PTCT
Higher net margin
PTCT
PTCT
7.4% more per $
PTCT
-82.0%
-89.4%
WOLF
More free cash flow
PTCT
PTCT
$36.0M more FCF
PTCT
$-36.6M
$-72.6M
WOLF
Faster 2-yr revenue CAGR
WOLF
WOLF
Annualised
WOLF
-8.4%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
PTCT
PTCT
WOLF
WOLF
Revenue
$164.7M
$168.5M
Net Profit
$-135.0M
$-150.6M
Gross Margin
-46.5%
Operating Margin
-43.3%
-94.0%
Net Margin
-82.0%
-89.4%
Revenue YoY
-22.7%
-6.6%
Net Profit YoY
-104.8%
59.5%
EPS (diluted)
$-1.63
$-5.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
WOLF
WOLF
Q4 25
$164.7M
$168.5M
Q3 25
$211.0M
$196.8M
Q2 25
$178.9M
$197.0M
Q1 25
$1.2B
$185.4M
Q4 24
$213.2M
$180.5M
Q3 24
$196.8M
$194.7M
Q2 24
$186.7M
$200.7M
Q1 24
$210.1M
$200.7M
Net Profit
PTCT
PTCT
WOLF
WOLF
Q4 25
$-135.0M
$-150.6M
Q3 25
$15.9M
$-643.6M
Q2 25
$-64.8M
$-669.3M
Q1 25
$866.6M
$-285.5M
Q4 24
$-65.9M
$-372.2M
Q3 24
$-106.7M
$-282.2M
Q2 24
$-99.2M
$-174.9M
Q1 24
$-91.6M
$-148.9M
Gross Margin
PTCT
PTCT
WOLF
WOLF
Q4 25
-46.5%
Q3 25
-39.2%
Q2 25
-13.0%
Q1 25
-12.1%
Q4 24
-20.6%
Q3 24
-18.6%
Q2 24
1.2%
Q1 24
11.2%
Operating Margin
PTCT
PTCT
WOLF
WOLF
Q4 25
-43.3%
-94.0%
Q3 25
1.4%
-82.0%
Q2 25
-19.5%
-295.2%
Q1 25
82.5%
-104.9%
Q4 24
-76.2%
-178.9%
Q3 24
-27.7%
-118.2%
Q2 24
-21.5%
-72.7%
Q1 24
-21.6%
-53.0%
Net Margin
PTCT
PTCT
WOLF
WOLF
Q4 25
-82.0%
-89.4%
Q3 25
7.5%
-327.0%
Q2 25
-36.3%
-339.7%
Q1 25
73.7%
-154.0%
Q4 24
-30.9%
-206.2%
Q3 24
-54.2%
-144.9%
Q2 24
-53.1%
-87.1%
Q1 24
-43.6%
-74.2%
EPS (diluted)
PTCT
PTCT
WOLF
WOLF
Q4 25
$-1.63
$-5.78
Q3 25
$0.20
$-4.12
Q2 25
$-0.83
$-4.42
Q1 25
$10.04
$-1.86
Q4 24
$-0.85
$-2.88
Q3 24
$-1.39
$-2.23
Q2 24
$-1.29
$-1.39
Q1 24
$-1.20
$-1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
WOLF
WOLF
Cash + ST InvestmentsLiquidity on hand
$1.9B
$1.3B
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$-205.3M
$627.4M
Total Assets
$2.9B
$3.4B
Debt / EquityLower = less leverage
3.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
WOLF
WOLF
Q4 25
$1.9B
$1.3B
Q3 25
$1.7B
$926.0M
Q2 25
$2.0B
$955.4M
Q1 25
$2.0B
$1.3B
Q4 24
$1.1B
$1.4B
Q3 24
$1.0B
$1.7B
Q2 24
$1.1B
$2.2B
Q1 24
$884.8M
$2.6B
Total Debt
PTCT
PTCT
WOLF
WOLF
Q4 25
$2.0B
Q3 25
$0
Q2 25
$6.5B
Q1 25
$6.5B
Q4 24
$6.4B
Q3 24
$6.2B
Q2 24
$6.2B
Q1 24
Stockholders' Equity
PTCT
PTCT
WOLF
WOLF
Q4 25
$-205.3M
$627.4M
Q3 25
$-155.8M
$-1.1B
Q2 25
$-206.5M
$-447.1M
Q1 25
$-185.8M
$212.7M
Q4 24
$-1.1B
$372.6M
Q3 24
$-1.1B
$628.9M
Q2 24
$-980.2M
$882.1M
Q1 24
$-893.9M
$1.0B
Total Assets
PTCT
PTCT
WOLF
WOLF
Q4 25
$2.9B
$3.4B
Q3 25
$2.6B
$6.6B
Q2 25
$2.6B
$6.9B
Q1 25
$2.7B
$7.6B
Q4 24
$1.7B
$7.7B
Q3 24
$1.8B
$7.9B
Q2 24
$1.9B
$8.0B
Q1 24
$1.8B
$7.7B
Debt / Equity
PTCT
PTCT
WOLF
WOLF
Q4 25
3.13×
Q3 25
Q2 25
Q1 25
30.61×
Q4 24
17.24×
Q3 24
9.81×
Q2 24
6.98×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
WOLF
WOLF
Operating Cash FlowLast quarter
$-34.3M
$-42.6M
Free Cash FlowOCF − Capex
$-36.6M
$-72.6M
FCF MarginFCF / Revenue
-22.3%
-43.1%
Capex IntensityCapex / Revenue
1.4%
17.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$-988.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
WOLF
WOLF
Q4 25
$-34.3M
$-42.6M
Q3 25
$-66.3M
$5.7M
Q2 25
$-58.3M
$-242.5M
Q1 25
$870.1M
$-142.1M
Q4 24
$-30.0M
$-195.1M
Q3 24
$-77.0M
$-132.0M
Q2 24
$-71.5M
$-239.5M
Q1 24
$70.8M
$-136.2M
Free Cash Flow
PTCT
PTCT
WOLF
WOLF
Q4 25
$-36.6M
$-72.6M
Q3 25
$-69.7M
$-98.3M
Q2 25
$-59.6M
$-454.4M
Q1 25
$868.4M
$-362.8M
Q4 24
$-33.8M
$-596.9M
Q3 24
$-77.5M
$-569.0M
Q2 24
$-78.8M
$-883.8M
Q1 24
$61.2M
$-713.7M
FCF Margin
PTCT
PTCT
WOLF
WOLF
Q4 25
-22.3%
-43.1%
Q3 25
-33.1%
-49.9%
Q2 25
-33.3%
-230.7%
Q1 25
73.8%
-195.7%
Q4 24
-15.8%
-330.7%
Q3 24
-39.4%
-292.2%
Q2 24
-42.2%
-440.4%
Q1 24
29.1%
-355.6%
Capex Intensity
PTCT
PTCT
WOLF
WOLF
Q4 25
1.4%
17.8%
Q3 25
1.6%
52.8%
Q2 25
0.7%
107.6%
Q1 25
0.1%
119.0%
Q4 24
1.8%
222.6%
Q3 24
0.3%
224.4%
Q2 24
4.0%
321.0%
Q1 24
4.6%
287.7%
Cash Conversion
PTCT
PTCT
WOLF
WOLF
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
1.00×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

WOLF
WOLF

Power Products$118.3M70%
Materials Products$50.2M30%

Related Comparisons